RLC Followed by CR-CHOP in Elderly Patients with Newly-diagnosed DEL

NCT06674096 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Double-expressor Lymphoma

Interventions

DRUG: RLC-CRCHOP

Sponsor

Zhejiang Cancer Hospital